Madison Parker Backs Klone Lab

The Boston-based private equity firm invests in Klone Lab, a Massachusetts maker of sport and lifestyle accessories. Madison Parker Capital typically provides investments to lower-middle market companies in sizes ranging from $5 million to $30 million.

PRESS RELEASE: Madison Parker Capital, an investment firm based in Boston, Massachusetts, today announced its investment in Klone Lab, a boutique licensing and product marketing company in the performance sport, action sport, and outdoor industry. Klone Lab will use this funding to accelerate its pursuit of new market opportunities and grow its product offerings.
Klone Lab, located in Amesbury, Massachusetts, is a full service global licensing company that specializes in design, manufacture and distribution of sports and lifestyle accessory products. With a unique focus on sandals, and open toe footwear, Klone understands your brands DNA and is geared to perform as an extension of your brand with an expertise in design, sourcing, distribution and strategic marketing. Klone Lab is the licensing house for New Balance Inc. sandals, slides and open toe products. For more information, please visit: www.klonemfg.com.

About Madison Parker Capital
Madison Parker Capital is a Boston-based investment firm focused exclusively on partnership-oriented investments in lower middle-market companies. Madison Parker works with existing management teams as well as experienced executives to sponsor minority and majority recapitalizations, growth, and consolidation transactions in a wide range of industries including business services, software, healthcare services, industrial/manufacturing, digital media/publishing and consumer/retail. Madison Parker targets companies with operating profits between $2 million and $10 million with investment sizes ranging from $5 million to $30 million. Madison Parker is located in Boston, Massachusetts and more information is available at www.madisonparkercapital.com.